FindTrial
Sign In

SHR-8068 Injection

DRUG5 trials

Sponsors

Shanghai Hengrui Pharmaceutical Co., Ltd., Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Conditions

Advanced Biliary Tract CancerAdvanced Urothelial CarcinomaColorectal CancerGastric CancerGastroesophageal-junction CancerResectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk

Phase 1

A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
RecruitingNCT06639347
Shanghai Hengrui Pharmaceutical Co., Ltd.Advanced Urothelial Carcinoma
Start: 2024-11-04End: 2027-05-31Target: 90Updated: 2024-11-18

Phase 2

A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
RecruitingNCT07071714
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Colorectal Cancer
Start: 2025-07-22End: 2031-10-01Target: 200Updated: 2026-03-18
A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
RecruitingNCT07110571
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Gastric Cancer, Gastroesophageal-junction Cancer
Start: 2025-08-28End: 2027-05-31Target: 200Updated: 2026-01-09
A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma
Not yet recruitingNCT07682272
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk
Start: 2026-07-01End: 2029-07-01Target: 120Updated: 2026-07-02

Phase 3

A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)
RecruitingNCT07229625
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Advanced Biliary Tract Cancer
Start: 2026-01-21End: 2029-12-01Target: 604Updated: 2026-01-28